/
THE COMPANY Cumberland Pharmaceuticals Inc. ("Cumberland," the "Company," or as used in the context of "we," "us" or "our"), is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription pharmaceuticals. We are dedicated to our mission of working together to provide unique products that improve the quality of patient care.
The business is unprofitable at the operating level (-6.27% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 17.6% YoY with margins expanding 10.7pp.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$42M
▲ +17.6% YoY
Net Income (TTM)
-$7M
▲ +56.2% YoY
Op. Margin
-17.20%
▲ +10.7pp YoY
ROIC
-18.92%
▲ +7.8pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$1M
▲ +812.4% YoY
Op. Cash Flow (TTM)
$1M
▲ +905.7% YoY
Net Debt
-$6M
Net Cash Position
Cash & Equiv.
$11M
5Y CAGR: +3.5%
5Y CAGR: -1.7%
Continue Research